Clinical scope and governance
Define appropriate indications, exclusions, referral rules and escalation pathways with radiology, oncology and haematology stakeholders.
Flagship clinical service
Whole-body MRI that works beyond the scanner room.
A scanner-specific, clinically responsible and operationally complete implementation programme for oncology, haematology and selected screening pathways.
More than a sequence list
Design acquisition, interpretation and delivery together.
The programme is adapted to the actual scanner, available coils, software level, team experience, patient population and local referral environment.
The launch framework
One programme, six connected workstreams.
Each workstream produces a tangible deliverable and a clear owner inside the organisation.
Scanner-specific protocol
Build and test acquisition for the installed hardware and software — including positioning, coverage, DWI strategy, anatomical sequences and contrast policy.
Reporting and interpretation
Create a structured approach to lesion assessment, comparison, response evaluation, incidental findings and multidisciplinary communication.
Patient and staff workflow
Design preparation, safety, booking, room turnover, scan supervision and quality-control procedures.
Team training
Hands-on education for radiologists and technologists, followed by supervised cases and performance review.
Service proposition and measurement
Align referral communication, patient-facing information, capacity, pricing logic and launch metrics without overstating clinical evidence.
Why implementation fails
A protocol alone does not create a service.
Clinical
Unclear indications, inconsistent interpretation or no escalation pathway can undermine confidence.
Technical
Copied protocols ignore hardware, coils, software, field strength, workflow and local image-quality constraints.
Operational
Without booking logic, patient preparation, reporting standards and ownership, adoption remains fragile.
Evidence and communication
Ambitious, but clinically responsible.
Whole-body MRI is powerful in selected oncologic and haematologic settings. Screening requires careful positioning because standardisation and outcome evidence continue to evolve.
The programme separates established indications from investigational or commercial screening use, with explicit governance and informed communication.
Recent professional work
Whole-body imaging across clinical and scientific settings.
ECR 2025 scientific work
Whole-body MRI in oncologic and haematologic imaging.
ESOI Touchdown 2025
Whole-body cancer screening: techniques, protocols and clinical limitations.
Hybrid-imaging perspective
Positioning MRI, DWI and PET according to mechanism, strengths and limitations.
For hospitals and imaging centres
Build the programme around your scanner, your team and your market.
The first discussion reviews installed technology, target indications, current expertise and the operational case for launch.